Navigation Links
Generex Provides Corporate Update
Date:8/2/2011

otherapy demonstrated positive early research data.  The Company recently entered into a binding letter agreement to license its RapidMist™ buccal drug delivery technologies to Amarantus BioSciences, Inc. (OTCBB: AMBS) for use with its proprietary MANF proteins in exchange for a non-refundable license fee of $10 million.  In addition, the companies will jointly pursue the development of a MANF-based biomarker test to diagnose patients in the very early stage of development of diabetes likely to respond to Generex Oral-lyn™ treatment.  The binding letter of agreement with Amarantus also calls for the license fee to be paid in Amarantus common stock.  The Company's intention is to dividend a portion of Amarantus shares to Generex stockholders after the completion of the reverse stock split and an effective registration of Amarantus shares to be owned by Generex.  Generex will also enhance a collaboration with Antigen Express in developing early identification of markers of immune system activation associated with the immunologic destruction of the beta cells, which may lead to immune system therapy that could prevent the development of diabetes.
  • Expanding Leadership.  The Company is actively broadening its leadership with the appointment of Mark Fletcher as President & Chief Executive Officer, Dr. David Brusegard, Ph.D. as Chief Operating Officer, Stephen Fellow as Acting Chief Financial Officer, Dr. James H. Anderson as Senior Scientific Advisor and Director (formerly with Eli Lilly and Company as a Senior Medical Director for Diabetes and Cardio-metabolic Medicine), and U.S. Congressman Curt Weldon (a Co-Founder of the Congressional Diabetes Caucus) as a corporate advisor.  In addition, Dr. Anderson and Dr. Eric von Hofe, current President of Antigen Express, were both elected to the Company's board of directors.

    '/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
2. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
3. Generex Announces Presentations of Novel Vaccine Strategies
4. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
5. Generex Announces Sales Agreement with Elias Shaker & Company
6. Generex Presents Abstract at EASD Annual Meeting
7. Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System
8. Generex Biotechnology Provides a Corporate Update to Address Managements Strategic Initiatives for Growth
9. Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies
10. Generex Provides Clarification for Special Meeting Voting
11. Generex Announces That Adjournment Will be Sole Matter Considered at Reconvened Special Meeting of Stockholders on October 15, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... , July 14, 2014 We are ... Center ("OACM") and the Ellicott City Ambulatory Surgery Center ... Ellicott City Maryland . ... Merritt Healthcare and 14 leading Orthopaedics, Sports Medicine, Hand, ... will also accommodate the specialties of general surgery and ...
(Date:7/14/2014)... de 2014 /PRNewswire-HISPANIC PR WIRE/ -- BioAdaptives, Inc. (OTCBB:BDPT) ... , presidente de la junta directiva, ha asumido las ... señor Epling es el dueño de Ferris Holding ... su formulación, sus propiedades intelectuales y otras tecnologías a ... "El señor Gerald Epling , que ha ...
(Date:7/14/2014)... July 14, 2014 Decision Resources Group ... positively influence perceptions of emerging drugs for both ... 100 oncologists (50 medical oncologists and 50 hematological ... of managed care organizations (MCOs), reveals that despite ... the majority of payers say this designation will ...
Breaking Medicine Technology:BioAdaptives se prepara para el próximo paso 2BioAdaptives se prepara para el próximo paso 3Breakthrough Therapy Designation is Likely to Sway Oncologists' Confidence in An Agent and Encourage Prescribing 2Breakthrough Therapy Designation is Likely to Sway Oncologists' Confidence in An Agent and Encourage Prescribing 3
... 2011  VIVUS, Inc. (NASDAQ: VVUS ) today ... in The American Journal of Clinical Nutrition, ... study evaluated the long-term efficacy and safety of Qnexa ... In addition to 10% sustained weight loss, the study ...
... Reportlinker.com announces that a new market research ... Global Coronary Stents Industry ... the worldwide markets for Coronary Stents in US$ ... Segments: Bare Metal Stents, and Drug Eluting Stents. ...
Cached Medicine Technology:SEQUEL Trial Results for Qnexa® Published in AJCN Show 10% Sustained Weight Loss Over 2 Years 2SEQUEL Trial Results for Qnexa® Published in AJCN Show 10% Sustained Weight Loss Over 2 Years 3SEQUEL Trial Results for Qnexa® Published in AJCN Show 10% Sustained Weight Loss Over 2 Years 4SEQUEL Trial Results for Qnexa® Published in AJCN Show 10% Sustained Weight Loss Over 2 Years 5SEQUEL Trial Results for Qnexa® Published in AJCN Show 10% Sustained Weight Loss Over 2 Years 6Global Coronary Stents Industry 2Global Coronary Stents Industry 3Global Coronary Stents Industry 4Global Coronary Stents Industry 5Global Coronary Stents Industry 6Global Coronary Stents Industry 7Global Coronary Stents Industry 8Global Coronary Stents Industry 9Global Coronary Stents Industry 10Global Coronary Stents Industry 11Global Coronary Stents Industry 12Global Coronary Stents Industry 13Global Coronary Stents Industry 14Global Coronary Stents Industry 15Global Coronary Stents Industry 16Global Coronary Stents Industry 17Global Coronary Stents Industry 18Global Coronary Stents Industry 19Global Coronary Stents Industry 20Global Coronary Stents Industry 21Global Coronary Stents Industry 22Global Coronary Stents Industry 23Global Coronary Stents Industry 24Global Coronary Stents Industry 25
(Date:7/14/2014)... According to a recent study ... a connection between women with high levels of a ... doctors have theorized about the role stress plays in ... provide scientific support. , “Stress, if very significant, can ... Barmat, an OB/GYN who specializes in reproductive endocrinology and ...
(Date:7/14/2014)... Last month Bromell Agency officially launched the new ... more detailed information on how clients can protect and ... boats in the state of Louisiana. , The agency ... website in order to better educate clients on the ... the website, which is to display comprehensive insurance information ...
(Date:7/14/2014)... 14, 2014 There’s an old adage that ... The Lash Palette say the products offered in their ... , “You can reserve The Lash Palette for $40,” said ... Store . , Paris explained that the first 1,000 have ... 21. , She went on to point out that her ...
(Date:7/14/2014)... 2014 Seven promising startup companies ... problems have been accepted into the University ... (DHA). , The awardees were selected from ... process. They include Biomeme, Fitly, Life Patch, Curbside ... France) and Pulse InfoFrame (from Canada) —both of ...
(Date:7/14/2014)... 2014 Jordan Valley Medical Center is ... comprehensive cancer center set to open by the fall ... only hospital west of I-15 in the Salt Lake ... Additionally, Jordan Valley Medical Center has partnered with Elekta, ... planning systems for radiation therapy, radiosurgery and brachytherapy, to ...
Breaking Medicine News(10 mins):Health News:Abington Health Physician Addresses Link Between Stress and Infertility 2Health News:Abington Health Physician Addresses Link Between Stress and Infertility 3Health News:The Lash Palette Preorder Event Has Officially Begun 2Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 2Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 3Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 4Health News:Jordan Valley Medical Center Set to Break Ground with New $10 Million Cancer Center 2
... day to day life. Keeping fit costs hardly anything if ... a gym or health club,// you'll be familiar with high ... These items typically cost thousands of dollars and might be ... But you can get the same results practically for free, ...
... lasers help remove lines and wrinkled from age and ... can take its toll in later years in terms ... But, says Dr Arielle Kauvar, a dermatologist at New ... smoother, firmer appearance. ,These lasers score over ...
... of botulinum toxin eases hand spasticity among stroke survivors. Spasticity ... and it causes much disability,// because it interferes with activities ... botulinum toxin - a substance that relieves muscle tightness - ... large trial of botulinum toxin (also known as botox) in ...
... may be combined with tumor growth in mice. At ... or similar pain medications will lead to increased cancer ... further studies for managing cancer pain. ,Researchers ... of morphine, similar to doses given to cancer patients ...
... potency can be influenced by various reasons. Many advertisments ... impotence to the attention of thousands of people.// Impotence ... men are taking help, particularly as large segments of ... range from 12 million to 30 million men in ...
... An acid found naturally in the body can block the ... There is no cure for Huntington's disease (HD), which is ... But researchers at the University of Texas may be one ... with HD. ,The mice were treated with a ...
Cached Medicine News:Health News:Many factors influence sexual potency 2
... and value!, Comfortable feel and ... contoured handle , Finer control while ... action , Completely autoclavable for easy ... for recalibration , Easy-to-read precision micrometer ...
... 3730 DNA Analyzer, upgradeable to 96 capillaries, ... analysis. , Higher optical sensitivity and ... data at a lower cost. , Multiple ... Optimized polymers increase your productivity without compromising ...
... this unique offer, you can ... application. Pipetman P2 and P10 ... reagents, and P100 is perfect ... Filter Tips, which are especially ...
... an immunochromatography based one step in ... determination of Methamphetamine in human urine ... ng/mL. This assay has not been ... and is for use by Healthcare ...
Medicine Products: